A phase 3 multicenter, randomized, placebo-controlled, d

  • Shepela, Chris (PI)

Project: Research project

Project Details

Description

A Phase 3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Maintenance Therapy, Administered Subcutaneously, in Subjects with Moderately to Severely Active Ulcerative Colitis
StatusFinished
Effective start/end date12/4/0712/31/14

Funding

  • Janssen Biotech, Inc.

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.